A perspective published in the Journal of Clinical Endocrinology and Metabolism titled "Approach to the Patient With Thyroid Nodules: Considering GLP-1 Receptor Agonists" concluded that GLP-1 receptor agonist therapy should not be withheld from patients with benign thyroid nodules
Mounjaro vs Wegovy vs Saxenda Weight Loss Effectiveness Based on clinical trials, the average weight loss is highest with Mounjaro, followed by Wegovy and then Saxenda
Branded FDA-approved alternatives (Ozempic, Wegovy, Mounjaro, Zepbound) are also available at manufacturer pricing, which typically runs $800 to $1,400 per month
Coronary and Peripheral Artery Disease GLP-1 RAs have shown mixed results in the management of CAD, particularly regarding MI outcomes
It is worth noting that the largest studies of GLP-1 receptor agonists in people with type 1 diabetes were performed with liraglutide (Victoza, Novo Nordisk), so greater HbA1c reductions and weight loss would be likely with use of higher potency agents, such as semaglutide (Ozempic and Rybelsus, Novo Nordisk) and tirzepatide (Mounjaro, Eli Lilly)
